Xiaoxi Liu

1.2k total citations · 1 hit paper
18 papers, 861 citations indexed

About

Xiaoxi Liu is a scholar working on Pharmacology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Xiaoxi Liu has authored 18 papers receiving a total of 861 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmacology, 6 papers in Cardiology and Cardiovascular Medicine and 5 papers in Surgery. Recurrent topics in Xiaoxi Liu's work include Antibiotic Resistance in Bacteria (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and Acute Myocardial Infarction Research (3 papers). Xiaoxi Liu is often cited by papers focused on Antibiotic Resistance in Bacteria (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and Acute Myocardial Infarction Research (3 papers). Xiaoxi Liu collaborates with scholars based in United States, China and Japan. Xiaoxi Liu's co-authors include Vijay Nambi, Christie M. Ballantyne, Lloyd E. Chambless, Eric Boerwinkle, Salim S. Virani, Aaron R. Folsom, Thomas H. Mosley, Brad C. Astor, Josef Coresh and James A. de Lemos and has published in prestigious journals such as Circulation, Nature Communications and Stroke.

In The Last Decade

Xiaoxi Liu

18 papers receiving 845 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cardiac Troponin T Measured by a Highly Sensitive Assay Predicts Coronary Heart Disease, Heart Failure, and Mortality in the Atherosclerosis Risk in Communities Study

2011 561 citations Justin T. Saunders, Vijay Nambi et al. Circulation profile →

Peers

Countries citing papers authored by Xiaoxi Liu

Since Specialization

Citations

This map shows the geographic impact of Xiaoxi Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoxi Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoxi Liu more than expected).

Fields of papers citing papers by Xiaoxi Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoxi Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoxi Liu. The network helps show where Xiaoxi Liu may publish in the future.

Co-authorship network of co-authors of Xiaoxi Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoxi Liu. A scholar is included among the top collaborators of Xiaoxi Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoxi Liu. Xiaoxi Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Chemosensory anhedonia facilitates depressive symptoms and cognitive impairment in late‐life depression 2024 ·Geriatrics and gerontology international ·Jiafu Li, Ben Chen, Qiang Wang, (unknown), Hanna Lu, (unknown), (unknown), (unknown), (unknown), Shuang Liang, Kexin Yao, Qin Liu, Yuanling Huang, Xiaoxi Liu, Xiaomei Zhong, Yuping Ning	1
2	Effects of individualized comprehensive nutritional support on inflammatory markers, serum amylase (AMS), prealbumin (PA), albumin (ALB), calcium ion (Ca2+) in patients with severe pancreatitis 2024 ·Journal of Medical Biochemistry ·Xiaoxi Liu, (unknown)	2
3	In vivo Pharmacokinetic/Pharmacodynamic Analysis of the Efficacy of the Cefepime/Nacubactam Combination Against β-Lactamase-Producing Enterobacterales based on the Instantaneous MIC Concept 2023 ·Pharmaceutical Research ·(unknown), (unknown), Xiaoxi Liu, (unknown), (unknown), Victor Tuan Giam Chuang, Yuki Enoki, Kazuaki Taguchi, Kazuaki Matsumoto	3
4	The Potential Roles of CHI3L1 in Failed Autologous Arteriovenous Fistula in End-Stage Renal Disease 2023 ·The Tohoku Journal of Experimental Medicine ·(unknown), Zhanghua Wang, Shasha Li, Xiaoxi Liu, (unknown), Lu Li	3
5	Mitral annular calcification in obstructive hypertrophic cardiomyopathy: Incidence, risk factors, and prognostic value after myectomy 2023 ·International Journal of Cardiology ·Zining Wu, (unknown), Changsheng Zhu, (unknown), (unknown), Tao Lu, Zhengyang Lu, Xiaoxi Liu, Shuiyun Wang	2
6	KSHV Viral Protein Kinase Interacts with USP9X to Modulate the Viral Lifecycle 2023 ·Journal of Virology ·Danielle L. Chappell, (unknown), Jason P. Wong, Aadra P. Bhatt, Xiaoxi Liu, Sara J. Buhrlage, Brenda Temple, Michael B. Major, Blossom Damania	4
7	Development of an optimized and practical pharmacokinetics/pharmacodynamics analysis method for aztreonam/nacubactam against carbapenemase-producingK. pneumoniae 2023 ·Journal of Antimicrobial Chemotherapy ·(unknown), (unknown), Xiaoxi Liu, (unknown), (unknown), Victor Tuan Giam Chuang, Yuki Enoki, Kazuaki Taguchi, Kazuaki Matsumoto	9
8	Differences in Pharmacokinetic/Pharmacodynamic Parameters of Tedizolid Against VRE and MRSA 2022 ·Pharmaceutical Research ·Xiaoxi Liu, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Yuki Enoki, Kazuaki Taguchi, Kazuaki Matsumoto	8
9	Ultrasonographic characteristics of thyroid nodule rupture after microwave ablation 2021 ·Medicine ·(unknown), (unknown), Xiaoxi Liu, Yiwen Ding, Zekai Zhang, Jing Li, Yanzhen Wang	6
10	Comparison of effects of midostaurin, crenolanib, quizartinib, gilteritinib, sorafenib and BLU‐285 on oncogenic mutants of KIT, CBL and FLT3 in haematological malignancies 2019 ·British Journal of Haematology ·Ellen Weisberg, Chengcheng Meng, Abigail E. Case, Martin Sattler, Hong L. Tiv, Prafulla C. Gokhale, Sara J. Buhrlage, Xiaoxi Liu, Jing Yang, Jinhua Wang, Nathanael S. Gray, Richard M. Stone, Sophia Adamia, Patrice Dubreuil, Sébastien Letard, J D Griffin	37
11	Precise through-space control of an abiotic electrophilic aromatic substitution reaction 2017 ·Nature Communications ·(unknown), (unknown), Xiaoxi Liu, (unknown), Patrick Lee, Jianing Li, Severin T. Schneebeli	15
12	Pharmacology of a traditional Chinese herb, Shuangren-Anshen capsule, in a hemorrhage mouse model by using an orthogonal array design 2016 ·Genetics and Molecular Research ·Xiaoxi Liu, (unknown), Xinliang Zhang, Yingying Wei, Xiaolu Song, (unknown)	1
13	Traditional Chinese herbal medicine ultrasonic atomization combined with bloodletting at Ěrjiān ( EX-HN 6) for acute catarrhal conjunctivitis: a randomized controlled trial 2016 ·World Journal of Acupuncture - Moxibustion ·Xiaoxi Liu, Huili Li, (unknown)	1
14	Intervention effect of traditional Chinese medicine Yi Tang Kang on metabolic syndrome of spleen deficiency 2015 ·Asian Pacific Journal of Tropical Medicine ·Xiaoxi Liu, (unknown)	8
15	Trends in Myocardial Infarction Rates and Case Fatality by Anatomical Location in Four United States Communities, 1987 to 2008 (from the Atherosclerosis Risk in Communities Study) 2013 ·The American Journal of Cardiology ·Jonathan Newman, Daichi Shimbo, C.D. Baggett, Xiaoxi Liu, Richard S. Crow, (unknown), Laura R. Loehr, Lisa Wruck, Aaron R. Folsom, Wayne D. Rosamond	19
16	Troponin T and N-Terminal Pro–B-Type Natriuretic Peptide: A Biomarker Approach to Predict Heart Failure Risk—The Atherosclerosis Risk in Communities Study 2013 ·Clinical Chemistry ·Vijay Nambi, Xiaoxi Liu, Lloyd E. Chambless, James A. de Lemos, Salim S. Virani, Sunil Agarwal, Eric Boerwinkle, Ron C. Hoogeveen, David Aguilar, Brad C. Astor, Pothur R. Srinivas, Anita Deswal, Thomas H. Mosley, Josef Coresh, Aaron R. Folsom, Gerardo Heiss, Christie M. Ballantyne	77
17	Cardiac Troponin T Measured by a Highly Sensitive Assay Predicts Coronary Heart Disease, Heart Failure, and Mortality in the Atherosclerosis Risk in Communities Study breakdown → 2011 ·Circulation ·Justin T. Saunders, Vijay Nambi, James A. de Lemos, Lloyd E. Chambless, Salim S. Virani, Eric Boerwinkle, Ron C. Hoogeveen, Xiaoxi Liu, Brad C. Astor, Thomas H. Mosley, Aaron R. Folsom, Gerardo Heiss, Josef Coresh, Christie M. Ballantyne	561
18	Carotid Arterial Wall Characteristics Are Associated With Incident Ischemic Stroke But Not Coronary Heart Disease in the Atherosclerosis Risk in Communities (ARIC) Study 2011 ·Stroke ·Eric Yang, Lloyd E. Chambless, A. Richey Sharrett, Salim S. Virani, Xiaoxi Liu, Zheng-Zheng Tang, Eric Boerwinkle, Christie M. Ballantyne, Vijay Nambi	104

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact